30 ms·
The cost to setup a process and maintain it according to FDA requirements. The market size is likely just under the cost to establish the manufacturing capacit
by ScottBev 11y ago
The cost to setup a process and maintain it according to FDA requirements.
The market size is likely just under the cost to establish the manufacturing capacity for the US market.
- twoodfin 11y agoAnd yet the "bad guy" generic manufacturer was able to raise the capital to do this (and presumably make a profit). What's the difference?
- ScottBev 11y agoTuring only acquired the US marketing rights. Someone else is making the drug. So that doesn't change the FDA licensing, but they get to increase the price in the US. http://www.prnewswire.com/news-releases/turing-pharmaceuticals-ag-acquires-us-marketing-rights-to-daraprim-pyrimethamine-300125853.html http://www.prnewswire.com/news-releases/turing-pharmaceutica...
- danmaz74 11y agoI guess that maintaining the process isn't that expensive, considering the previous price (which, I'm pretty sure, wasn't kept at a loss). So, probably, it's setting the process up which is expensive.